OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
Ganesh Yadagiri, Aakriti Singh, Kanika Arora, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 14
Ganesh Yadagiri, Aakriti Singh, Kanika Arora, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 14
Showing 14 citing articles:
Global Health Priority Box: Discovering Flucofuron as a Promising Antikinetoplastid Compound
Carlos J. Bethencourt-Estrella, Atteneri López‐Arencibia, Jacob Lorenzo‐Morales, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 554-554
Open Access | Times Cited: 4
Carlos J. Bethencourt-Estrella, Atteneri López‐Arencibia, Jacob Lorenzo‐Morales, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 554-554
Open Access | Times Cited: 4
Review of host-directed immunotherapy and candidate agents against leishmaniasis
Mebratu Tamir, Bisrat Birke Teketelew, Dereje Mengesha Berta, et al.
Frontiers in Tropical Diseases (2025) Vol. 6
Open Access
Mebratu Tamir, Bisrat Birke Teketelew, Dereje Mengesha Berta, et al.
Frontiers in Tropical Diseases (2025) Vol. 6
Open Access
Synthetic biology for combating leishmaniasis
Shweta Khandibharad, Shailza Singh
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Shweta Khandibharad, Shailza Singh
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Acrylonitrile derivatives: In vitro activity and mechanism of cell death induction against Trypanosoma cruzi and Leishmania amazonensis
Carlos J. Bethencourt-Estrella, Samuel Delgado‐Hernández, Atteneri López‐Arencibia, et al.
International Journal for Parasitology Drugs and Drug Resistance (2024) Vol. 24, pp. 100531-100531
Open Access | Times Cited: 2
Carlos J. Bethencourt-Estrella, Samuel Delgado‐Hernández, Atteneri López‐Arencibia, et al.
International Journal for Parasitology Drugs and Drug Resistance (2024) Vol. 24, pp. 100531-100531
Open Access | Times Cited: 2
PLGA nanoparticle-delivered Leishmania antigen and TLR agonists as a therapeutic vaccine against cutaneous leishmaniasis in BALB/c mice
Asal Katebi, Farhad Riazi‐Rad, Reyhaneh Varshochian, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112538-112538
Closed Access | Times Cited: 2
Asal Katebi, Farhad Riazi‐Rad, Reyhaneh Varshochian, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112538-112538
Closed Access | Times Cited: 2
Liposomal dual delivery systems in visceral leishmaniasis enhance the synergistic effects of combination therapy: A promise for the future
Raghunath Hazra, Amrita Kar, Santanu Kar Mahapatra
Asian Pacific Journal of Tropical Medicine (2024) Vol. 17, Iss. 2, pp. 47-60
Open Access | Times Cited: 1
Raghunath Hazra, Amrita Kar, Santanu Kar Mahapatra
Asian Pacific Journal of Tropical Medicine (2024) Vol. 17, Iss. 2, pp. 47-60
Open Access | Times Cited: 1
Advancing Treatment for Leishmaniasis: From Overcoming Challenges to Embracing Therapeutic Innovations
Vishal Singh, Rahul Tiwari, Rajneesh, et al.
ACS Infectious Diseases (2024)
Closed Access | Times Cited: 1
Vishal Singh, Rahul Tiwari, Rajneesh, et al.
ACS Infectious Diseases (2024)
Closed Access | Times Cited: 1
In silico and immunoinformatics based multiepitope subunit vaccine design for protection against visceral leishmaniasis
Deep Bhowmik, A Bhuyan, Seshan Gunalan, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9731-9752
Closed Access | Times Cited: 3
Deep Bhowmik, A Bhuyan, Seshan Gunalan, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9731-9752
Closed Access | Times Cited: 3
The Future of Leishmaniasis Treatment: Protein Targets and Beyond
Carlos A. Padilla, María-José Álvarez, Emmanuel Campo, et al.
(2023)
Open Access | Times Cited: 1
Carlos A. Padilla, María-José Álvarez, Emmanuel Campo, et al.
(2023)
Open Access | Times Cited: 1
The Future of Leishmaniasis Treatment: Protein Targets and Beyond
Carlos A. Padilla, María José Álvarez Álvarez, Emmanuel Campo, et al.
(2023)
Open Access | Times Cited: 1
Carlos A. Padilla, María José Álvarez Álvarez, Emmanuel Campo, et al.
(2023)
Open Access | Times Cited: 1
Managing visceral leishmaniasis
N.K. Bansal, Ankur Jain
BMJ (2023), pp. p2213-p2213
Closed Access | Times Cited: 1
N.K. Bansal, Ankur Jain
BMJ (2023), pp. p2213-p2213
Closed Access | Times Cited: 1
Pyridoxal kinase gene deletion leads to impaired growth, deranged redox metabolism and cell cycle arrest in Leishmania donovani
Pradyot Kumar Roy, Anindita Paul, Sandra Lalchhuanawmi, et al.
Biochimie (2024) Vol. 222, pp. 72-86
Closed Access
Pradyot Kumar Roy, Anindita Paul, Sandra Lalchhuanawmi, et al.
Biochimie (2024) Vol. 222, pp. 72-86
Closed Access
Host directed immunotherapy for chronic infections and cancer
Rahul Kumar Tiwari, Vishal Kumar Singh, Vibhav Gautam, et al.
Advances in protein chemistry and structural biology (2024), pp. 355-388
Closed Access
Rahul Kumar Tiwari, Vishal Kumar Singh, Vibhav Gautam, et al.
Advances in protein chemistry and structural biology (2024), pp. 355-388
Closed Access
Exploring immunotherapy to control human infectious diseases
Praveen Rai, Sanjana Mehrotra, Vijay Kumar Prajapati
Advances in protein chemistry and structural biology (2024), pp. 389-429
Closed Access
Praveen Rai, Sanjana Mehrotra, Vijay Kumar Prajapati
Advances in protein chemistry and structural biology (2024), pp. 389-429
Closed Access
